Switch to: References

Add citations

You must login to add citations.
  1. (1 other version)Access to medicines.Thomas Pogge - 2008 - Public Health Ethics 1 (2):73-82.
    Professor Thomas Pogge, Professorial Fellow, Centre for Applied Philosophy, LPO Box 8260, Canberra. Tel.: +61 261255485; Email: tp6{at}columbia.edu ' + u + '@' + d + ' '//--> Abstract I would pay three million to go into space, says the banker to his attorney. — I wouldn't go if you paid me, the latter laughs, for me the French Riviera is quite exciting enough. Ah, I would pay a million for an extra year of life , the elderly tourist effusively (...)
    Download  
     
    Export citation  
     
    Bookmark   14 citations  
  • Specifying Rights: the Case of TRIPS.G. Collste - 2011 - Public Health Ethics 4 (1):63-69.
    The TRIPS agreement has been widely discussed. Critics have accused it to favour property rights at the cost of public health in AIDS-stricken development countries. In this article, the conflict between on the one hand Intellectual Property Rights and on the other a right to subsistence is analysed with the help of a method for specification. The rationalization of TRIPS and its amendments raises two questions for ethics, one normative and one meta-ethical. First, which right has priority: the right to (...)
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  • (1 other version)Special Issue: Access to Medicines.T. Pogge - 2008 - Public Health Ethics 1 (2):73-82.
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Incentivizing access and innovation for essential medicines: A survey of the problem and proposed solutions.Michael Ravvin - 2008 - Public Health Ethics 1 (2):110-123.
    Michael Ravvin, Department of Political Science, Columbia University, 420 W. 118th Street, New York, NY 10027 Email: mer2133{at}columbia.edu ' + u + '@' + d + ' '//--> Abstract The existing intellectual property regime discourages the innovation of, and access to, essential medicines for the poor in developing countries. A successful proposal to reform the existing system must address these challenges of access and innovation. This essay will survey the problems in the existing pharmaceutical patent system and offer critical analysis (...)
    Download  
     
    Export citation  
     
    Bookmark   11 citations